focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMajedie Inv. Regulatory News (MAJE)

Share Price Information for Majedie Inv. (MAJE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.00
Bid: 240.00
Ask: 248.00
Change: 2.00 (0.81%)
Spread: 8.00 (3.333%)
Open: 248.00
High: 248.00
Low: 248.00
Prev. Close: 246.00
MAJE Live PriceLast checked at -
Majedie is an Investment Trust

To maximise total shareholder return whilst increasing dividends by more than the rate of inflation over the long-term by investing in securities of publicly quoted companies worldwide, though it may invest in unquoted securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Jul 2020 15:54

RNS Number : 7614R
Majedie Investments PLC
01 July 2020
 

1 July 2020

Majedie Investments PLC

 

Directorate Changes

 

The Board is delighted to announce that with effect from 1 July 2020, Christopher Getley and Richard Killingbeck have been appointed to the Board as Non-Executive Directors. They have also been appointed as members of the Audit, Remuneration, Management Engagement and Nomination Committees from this date.

 

The Board also announces the retirement of Paul Gadd, who has served on the Board since 2009, with effect from 31 July 2020. The Board would like to thank him for his wise counsel as a member of the Board and also as Chairman of the Remuneration and Management Engagement Committees. Upon Mr Gadd's resignation, Jane Lewis will become Chairman of the Remuneration Committee and David Henderson will become Chairman of the Management Engagement Committee.

 

Mr Getley has extensive knowledge of the investment industry as a Partner and Fund Manager at Cazenove and as a Director of Morgan Grenfell Asset Management. Subsequently, he was CEO of Westhouse Securities, an institutional stockbroker. He is currently Executive Chairman of AgPlus Diagnostics Limited and Non-Executive Chairman of Masawara PLC, a Southern Africa focussed investment company.

 

Mr Killingbeck has over 35 years' experience in the financial services sector, initially as a fund manager and latterly in a number of senior management roles within the wealth management sector. He was previously Chief Executive Officer of WH Ireland Group PLC and is currently Managing Director of Harris Allday, a subsidiary of EFG Private Bank. He retired as the Non-Executive Chairman of Bankers Investment Trust PLC in 2019 and is currently a trustee of the London Stock Exchange Benevolent Fund.

 

There is no information concerning Mr Getley or Mr Killingbeck that is required to be disclosed pursuant to Listing Rule 9.6.13R (2) to (6) inclusive and the Board considers them to be independent on appointment in accordance with the AIC Code of Corporate Governance. Mr Getley and Mr Killingbeck currently own 33,830 and 20,000 shares in the Company respectively.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFLFESDFILIII
Date   Source Headline
25th Aug 202312:58 pmRNSNet Asset Value(s)
10th Aug 20236:13 pmRNSNet Asset Value(s)
2nd Aug 20237:00 amRNSDividend Declaration
1st Aug 20234:12 pmRNSTotal Voting Rights
28th Jul 202311:52 amRNSDirector/PDMR Shareholding
25th Jul 202312:30 pmRNSNet Asset Value(s)
25th Jul 202312:29 pmRNSNet Asset Value(s)
10th Jul 20236:14 pmRNSNet Asset Value(s)
3rd Jul 202311:30 amRNSTotal Voting Rights
26th Jun 20236:13 pmRNSNet Asset Value(s)
26th Jun 20236:12 pmRNSNet Asset Value(s)
15th Jun 20235:53 pmRNSBlock listing Interim Review
12th Jun 20231:08 pmRNSNet Asset Value(s)
1st Jun 202312:30 pmRNSTotal Voting Rights
26th May 20237:00 amRNSHalf-year Report
25th May 20234:45 pmRNSNet Asset Value(s)
25th May 20234:43 pmRNSNet Asset Value(s)
10th May 20235:57 pmRNSNet Asset Value(s)
5th May 20237:00 amRNSDividend Declaration
2nd May 20235:04 pmRNSTotal Voting Rights
27th Apr 20235:58 pmRNSNet Asset Value(s)
27th Apr 20235:56 pmRNSNet Asset Value(s)
11th Apr 20239:33 amRNSNet Asset Value(s)
3rd Apr 20234:17 pmRNSTotal Voting Rights
30th Mar 20237:00 amRNSKepler Trust Intelligence: New Research
27th Mar 20235:32 pmRNSNet Asset Value(s)
27th Mar 20235:29 pmRNSNet Asset Value(s)
13th Mar 20233:39 pmRNSNet Asset Value(s)
1st Mar 20232:50 pmRNSRevised Timetable for Publication of the NAV
1st Mar 20232:39 pmRNSNet Asset Value(s)
1st Mar 20232:01 pmRNSTotal Voting Rights
28th Feb 20231:12 pmRNSNet Asset Value(s)
27th Feb 202312:48 pmRNSNet Asset Value(s)
24th Feb 202311:16 amRNSNet Asset Value(s)
23rd Feb 20233:30 pmRNSNet Asset Value(s)
22nd Feb 202312:24 pmRNSNet Asset Value(s)
21st Feb 202312:30 pmRNSNet Asset Value(s)
20th Feb 20233:51 pmRNSNet Asset Value(s)
17th Feb 20233:27 pmRNSNet Asset Value(s)
16th Feb 202312:50 pmRNSNet Asset Value(s)
15th Feb 202312:41 pmRNSNet Asset Value(s)
14th Feb 20232:32 pmRNSNet Asset Value(s)
13th Feb 20231:26 pmRNSNet Asset Value(s)
10th Feb 20232:15 pmRNSNet Asset Value(s)
9th Feb 20232:17 pmRNSNet Asset Value(s)
8th Feb 202312:47 pmRNSNet Asset Value(s)
7th Feb 20232:57 pmRNSNet Asset Value(s)
6th Feb 202312:48 pmRNSNet Asset Value(s)
3rd Feb 20231:44 pmRNSNet Asset Value(s)
2nd Feb 202312:06 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.